Arena Pharmaceuticals Inc. (ARNA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Arena Pharmaceuticals Inc...

NASDAQ: ARNA · Real-Time Price · USD
99.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Arena Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-155.61M -196.31M -146.09M -118.42M
Depreciation & Amortization
954K 971K 973K 974K
Stock-Based Compensation
18.27M 17.31M 17.79M 17.02M
Other Working Capital
640K -12.11M 29.34M -8.09M
Other Non-Cash Items
2.87M 72.49M 2.73M -11.1M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
13.02M -12.15M 30.77M -8.46M
Operating Cash Flow
-120.5M -117.69M -93.84M -119.99M
Capital Expenditures
-533K -70.15M -205K -97K
Cash Acquisitions
n/a 70M n/a n/a
Purchase of Investments
-201.9M -139.63M -109.5M -161.18M
Sales Maturities Of Investments
151.52M 192.4M 272.3M 388.38M
Other Investing Acitivies
n/a -70M n/a n/a
Investing Cash Flow
-50.92M -17.38M 162.59M 227.11M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
9.13M 7.46M 12.42M 106.39M
Financial Cash Flow
9.13M 7.46M 12.42M 106.39M
Net Cash Flow
-162.08M -127.52M 81.2M 213.43M
Free Cash Flow
-121.03M -187.85M -94.04M -120.09M